Viral latency and transformation: The strategy of Epstein-Barr virus
- 1 July 1989
- Vol. 58 (1) , 5-8
- https://doi.org/10.1016/0092-8674(89)90394-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- An intricate route to immortalityCell, 1989
- Differential expression of hla antigen of HLA anigens on human B-cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells?International Journal of Cancer, 1988
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- DNA methylation and gene activityCell, 1988
- Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsNature, 1988
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphomaInternational Journal of Cancer, 1985
- Virology: Epstein–Barr virus in epitheliumNature, 1984
- Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious MononucleosisNew England Journal of Medicine, 1977
- EBV‐determined nuclear antigen (EBNA)‐positive cells in the peripheral blood of infectious mononucleosis patientsInternational Journal of Cancer, 1976